A phase I pharmacokinetic and pharmacodynamic trial of Cannabidiol/tetrahydrocannabinol chewing gum (MedChew-1401)

Trial Profile

A phase I pharmacokinetic and pharmacodynamic trial of Cannabidiol/tetrahydrocannabinol chewing gum (MedChew-1401)

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Multiple sclerosis; Pain
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 03 Nov 2016 Status changed from planning to completed, according to an Axim Biotech product pipeline. (http://aximbiotech.com/product-timeline/)
    • 08 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top